Five-year heart study for Imatron (US):
This article was originally published in Clinica
Executive Summary
Imatron (US) and the University of Washington are collaborating in a new study of heart disease patients using Imatron's HeartScan coronary artery CT system to determine the degree of coronary artery calcification. The first of 160 patients with coronary artery disease and low HDL levels have undergone baseline coronary artery scans at Imatron's HeartScan-Seattle Coronary Artery Disease Risk Assessment Center. Serial scan findings will be compared with clinical and angiographic findings. Patients are to be assigned to three treatment groups, in the five-year double-blind study, to assess the magnitude and mechanism of beneficial drugs and vitamins on coronary artery disease.